Entera Bio annual return on equity
2019
2020
2021
2022
2023
2024
2025
Entera Bio Return on Equity (ROE) Growth & History (ENTX)
Entera Bio's return on equity was −108.01% for fiscal 2025.
View full Entera Bio company overviewEntera Bio annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −108.01% | −4.68 pp |
| 2024 | 2024-12-31 | −103.34% | −23.04 pp |
| 2023 | 2023-12-31 | −80.30% | −4.12 pp |
| 2022 | 2022-12-31 | −76.17% | +4.87 pp |
| 2021 | 2021-12-31 | −81.04% | +24.35 pp |
| 2020 | 2020-12-31 | −105.39% | −15.02 pp |
| 2019 | 2019-12-31 | −90.37% | — |
Entera Bio quarterly return on equity
Q2.20
Q2.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −81.46% | −66.96 pp |
| Q1 2026 | 2026-03-31 | −29.47% | −10.77 pp |
| Q4 2025 | 2025-12-31 | −21.29% | +11.16 pp |
| Q3 2025 | 2025-09-30 | −19.70% | +20.62 pp |
| Q2 2025 | 2025-06-30 | −14.50% | +10.16 pp |
| Q1 2025 | 2025-03-31 | −18.70% | +2.26 pp |
| Q4 2024 | 2024-12-31 | −32.45% | −8.45 pp |
| Q3 2024 | 2024-09-30 | −40.32% | −7.44 pp |
| Q2 2024 | 2024-06-30 | −24.66% | +0.73 pp |
| Q1 2024 | 2024-03-31 | −20.96% | −0.90 pp |
| Q4 2023 | 2023-12-31 | −24.00% | −0.72 pp |
| Q3 2023 | 2023-09-30 | −32.89% | −13.46 pp |
| Q2 2023 | 2023-06-30 | −25.39% | −8.18 pp |
| Q1 2023 | 2023-03-31 | −20.06% | −2.17 pp |
| Q4 2022 | 2022-12-31 | −23.29% | −6.50 pp |
| Q3 2022 | 2022-09-30 | −19.42% | — |
| Q2 2022 | 2022-06-30 | −17.21% | −1.96 pp |
| Q1 2022 | 2022-03-31 | −17.89% | — |
| Q4 2021 | 2021-12-31 | −16.79% | — |
| Q2 2021 | 2021-06-30 | −15.25% | +15.12 pp |
| Q2 2020 | 2020-06-30 | −30.38% | — |
Entera Bio return on equity trends
Over the last five fiscal years, Entera Bio's return on equity decreased from −105.39% to −108.01%, a change of −2.62 percentage points. The latest reported quarter, Q2 2026, shows −81.46%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Entera Bio source filings ↗